dalotuzumab

chemical compound

Uses your system voice; voice and rate in settings.

Q5211586Snapshot

≈ 1 min read

Names in other languages

  • العربيةدالوتوزوماب
  • Englishdalotuzumab

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Dalotuzumab is an anti-IGF1 receptor (IGF1R) humanized monoclonal antibody designed for the potential treatment of various cancers. Common adverse effects include hyperglycemia, nausea, vomiting, and fatigue. Dalotuzumab was developed by Merck and Co., Inc.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1330456953 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.